Substances with antineoplastic activity. 28. Cytostatic and pharmacologic properties of beta-4-methoxybenzoyl-beta-bromacrylic acid sodium salt.
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000633:toxicity; D001219:Aspartate Aminotransferases / Q000097:blood; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002455:Cell Division / Q000187:drug effects; D005260:Female; D007651:Keto Acids / Q000097:blood; D007783:Lactones / Q000494:pharmacology* / Q000633:toxicity; D008113:Liver Neoplasms / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011379:Prognosis; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy; D012517:Sarcoma, Yoshida / Q000188:drug therapy; D012964:Sodium / Q000494:pharmacology
D000970:Antineoplastic Agents; D007651:Keto Acids; D007783:Lactones; D012964:Sodium; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase